Laurel Wealth Advisors (North Carolina)’s Asensus Surgical, Inc. ASXC Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5	Closed	-$2	–	754
2024 Q2	$2	Buy	+5	New	+$1	﹤0.01%	651

Other funds holding ASXC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s ASXC Position: Q3 2024 in Review

Laurel Wealth Advisors (North Carolina) sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 5 shares — an estimated $2 sold.

Laurel Wealth Advisors (North Carolina) first reported a position in ASXC in Q2 2024 and held it in 1 quarter. The position peaked at $2 in Q2 2024. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

Laurel Wealth Advisors (North Carolina) reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 5 Asensus Surgical, Inc. shares in Q3 2024, an estimated $2.
Laurel Wealth Advisors (North Carolina) first reported a position in Asensus Surgical, Inc. in Q2 2024 and held it in 1 quarter.
Laurel Wealth Advisors (North Carolina)'s Asensus Surgical, Inc. position peaked at $2 in Q2 2024.
1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2024, filed 5 Nov 2024.